Prospecting Biomarkers for Diagnostic and Therapeutic Approaches in Pythiosis
- PMID: 34071174
- PMCID: PMC8229905
- DOI: 10.3390/jof7060423
Prospecting Biomarkers for Diagnostic and Therapeutic Approaches in Pythiosis
Abstract
Pythiosis, whose etiological agent is the oomycete Pythium insidiosum, is a life-threatening disease that occurs mainly in tropical and subtropical countries, affecting several animal species. It is frequently found in horses in Brazil and humans in Thailand. The disease is difficult to diagnose because the pathogen's hyphae are often misdiagnosed as mucoromycete fungi in histological sections. Additionally, there is no specific antigen to use for rapid diagnosis, the availability of which could improve the prognosis in different animal species. In this scenario, we investigated which P. insidiosum antigens are recognized by circulating antibodies in horses and humans with pythiosis from Brazil and Thailand, respectively, using 2D immunoblotting followed by mass spectrometry for the identification of antigens. We identified 23 protein spots, 14 recognized by pooled serum from horses and humans. Seven antigens were commonly recognized by both species, such as the heat-shock cognate 70 KDa protein, the heat-shock 70 KDa protein, glucan 1,3-beta-glucosidase, fructose-bisphosphate aldolase, serine/threonine-protein phosphatase, aconitate hydratase, and 14-3-3 protein epsilon. These results demonstrate that there are common antigens recognized by the immune responses of horses and humans, and these antigens may be studied as biomarkers for improving diagnosis and treatment.
Keywords: Pythium insidiosum; antigens; diagnosis; immunoproteomics; pythiosis; therapy.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures
Similar articles
-
History and Perspective of Immunotherapy for Pythiosis.Vaccines (Basel). 2021 Sep 26;9(10):1080. doi: 10.3390/vaccines9101080. Vaccines (Basel). 2021. PMID: 34696188 Free PMC article. Review.
-
Identification of a novel 74-kiloDalton immunodominant antigen of Pythium insidiosum recognized by sera from human patients with pythiosis.J Clin Microbiol. 2006 May;44(5):1674-80. doi: 10.1128/JCM.44.5.1674-1680.2006. J Clin Microbiol. 2006. PMID: 16672392 Free PMC article.
-
An initial survey of 150 horses from Thailand for anti-Pythium insidiosum antibodies.J Mycol Med. 2021 Mar;31(1):101085. doi: 10.1016/j.mycmed.2020.101085. Epub 2020 Nov 17. J Mycol Med. 2021. PMID: 33259982
-
Inferring putative virulence factors for Pythium insidiosum by proteomic approach.Med Mycol. 2019 Jan 1;57(1):92-100. doi: 10.1093/mmy/myx166. Med Mycol. 2019. PMID: 29373751
-
Pythium insidiosum: an overview.Vet Microbiol. 2010 Nov 20;146(1-2):1-16. doi: 10.1016/j.vetmic.2010.07.019. Epub 2010 Jul 24. Vet Microbiol. 2010. PMID: 20800978 Review.
Cited by
-
Selection of an Appropriate In Vitro Susceptibility Test for Assessing Anti-Pythium insidiosum Activity of Potassium Iodide, Triamcinolone Acetonide, Dimethyl Sulfoxide, and Ethanol.J Fungi (Basel). 2022 Oct 24;8(11):1116. doi: 10.3390/jof8111116. J Fungi (Basel). 2022. PMID: 36354883 Free PMC article.
-
History and Perspective of Immunotherapy for Pythiosis.Vaccines (Basel). 2021 Sep 26;9(10):1080. doi: 10.3390/vaccines9101080. Vaccines (Basel). 2021. PMID: 34696188 Free PMC article. Review.
References
-
- Krajaejun T., Sathapatayavongs B., Pracharktam R., Nitiyanant P., Leelachaikul P., Wanachiwanawin W., Chaiprasert A., Assanasen P., Saipetch M., Mootsikapun P., et al. Clinical and epidemiological analyses of human pythiosis in Thailand. Clin. Infect. Dis. 2006;43:569–576. doi: 10.1086/506353. - DOI - PubMed
-
- Mendoza L., Ajello L., McGinnis M.R. Infection caused by the Oomycetous pathogen Pythium insidiosum. J. Mycol. Med. 1996;6:151–164.
Grants and funding
LinkOut - more resources
Full Text Sources